TW200833841A - Medicine and method for treatment or prevention of degeneration of articular cartilage - Google Patents
Medicine and method for treatment or prevention of degeneration of articular cartilageInfo
- Publication number
- TW200833841A TW200833841A TW096149635A TW96149635A TW200833841A TW 200833841 A TW200833841 A TW 200833841A TW 096149635 A TW096149635 A TW 096149635A TW 96149635 A TW96149635 A TW 96149635A TW 200833841 A TW200833841 A TW 200833841A
- Authority
- TW
- Taiwan
- Prior art keywords
- articular cartilage
- medicine
- degeneration
- apoptosis
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention aims to offer the medicine and the method by which the apoptosis of the articular cartilage in arthrosis deformans etc. can be effectively controlled. The present invention relates to a medicine characterized in that controls for the apoptosis of the articular cartilage assuming the osteoclast formation control factor to be an active ingredient, and it concerns the method characterized in that controls for the apoptosis of the articular cartilage by administering the osteoclast formation control factor to the test specimen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006347095 | 2006-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200833841A true TW200833841A (en) | 2008-08-16 |
Family
ID=39562381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096149635A TW200833841A (en) | 2006-12-25 | 2007-12-24 | Medicine and method for treatment or prevention of degeneration of articular cartilage |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2008078588A1 (en) |
TW (1) | TW200833841A (en) |
WO (1) | WO2008078588A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030211106A1 (en) * | 2000-08-21 | 2003-11-13 | Tornetta Mark A | Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
PT1757619E (en) * | 2001-04-03 | 2010-03-25 | Nestle Sa | Osteoprotegerin in milk |
US20050244931A1 (en) * | 2001-04-12 | 2005-11-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
-
2007
- 2007-12-17 JP JP2008551037A patent/JPWO2008078588A1/en active Pending
- 2007-12-17 WO PCT/JP2007/074212 patent/WO2008078588A1/en active Application Filing
- 2007-12-24 TW TW096149635A patent/TW200833841A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008078588A1 (en) | 2008-07-03 |
JPWO2008078588A1 (en) | 2010-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
MTP4289B (en) | Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors | |
JO3002B1 (en) | Compounds and compositions as protein kinase inhibitors | |
TW200745109A (en) | Pyrrolo-pyridine kinase modulators | |
MY152033A (en) | Anti-siglec-15 antibody | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
WO2010021693A3 (en) | Mif modulators | |
MX351083B (en) | Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers. | |
MX2009003456A (en) | Compounds and compositions as protein kinase inhibitors. | |
WO2011140202A3 (en) | Mif modulators | |
MX2009005114A (en) | Use of gabapentin and pregabalin prodrugs for treating tinnitus. | |
NZ602478A (en) | Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate | |
MY148985A (en) | 2-aminopyridine analogs as glucokinase activators | |
MX2012004078A (en) | Compounds and compositions as modulators of gpr119 activity. | |
MA33810B1 (en) | COMPOSITIONS FOR TREATING NAUSEA AND VOMITING WITH CENTRAL MEDIATION | |
MX2009005725A (en) | Methods and compositions for treating and monitoring treatment of il-13-associated disorders. | |
BR112012013888A2 (en) | cytokine antagonist and corticosteroid combination preparations | |
IN2012DN02624A (en) | ||
MX2009004134A (en) | Treatment of demyelinating disorders. | |
EA201001749A1 (en) | METHOD OF TREATMENT OF DIFFERENTIATED ARTHRITIS | |
WO2007084535A3 (en) | Neuronal nicotinic receptor ligands and their use | |
HK1126194A1 (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same | |
WO2011014520A3 (en) | Compounds and compositions as modulators of gpr119 activity | |
WO2010042212A3 (en) | Methods for treating or preventing pain using spicamycin derivatives | |
IL196896A0 (en) | Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on ghs-r1a as an active ingredient |